Arrowstreet Capital, Limited Partnership Taro Pharmaceutical Industries LTD Transaction History

Arrowstreet Capital, Limited Partnership

$121 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$40.97 - $43.33 $792,032 - $837,655	19,332 Added 48.87%	58,888 $2.49 Million
Q4 2023 Feb 14, 2024	SELL	$32.77 - $42.31 $1.03 Million - $1.32 Million	-31,314 Reduced 44.19%	39,556 $1.65 Million
Q3 2023 Nov 14, 2023	BUY	$35.46 - $40.13 $2.51 Million - $2.84 Million	70,870 New	70,870 $2.67 Million
Q3 2021 Nov 12, 2021	SELL	$62.34 - $73.38 $269,807 - $317,588	-4,328 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$70.26 - $76.64 $304,085 - $331,697	4,328 New	4,328 $311,000
Q4 2020 Feb 12, 2021	SELL	$54.4 - $73.42 $1.28 Million - $1.73 Million	-23,607 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$54.41 - $68.2 $902,281 - $1.13 Million	-16,583 Reduced 41.26%	23,607 $1.3 Million
Q2 2020 Aug 12, 2020	BUY	$61.66 - $70.16 $2.23 Million - $2.54 Million	36,190 Added 904.75%	40,190 $2.67 Million
Q1 2020 May 15, 2020	SELL	$59.35 - $88.73 $3 Million - $4.48 Million	-50,506 Reduced 92.66%	4,000 $245,000
Q4 2019 Feb 13, 2020	SELL	$74.18 - $97.92 $6.19 Million - $8.17 Million	-83,393 Reduced 60.47%	54,506 $4.79 Million
Q3 2019 Nov 14, 2019	SELL	$75.36 - $86.57 $1.05 Million - $1.21 Million	-13,980 Reduced 9.2%	137,899 $10.4 Million
Q2 2019 Aug 14, 2019	SELL	$83.92 - $108.88 $1.26 Million - $1.64 Million	-15,063 Reduced 9.02%	151,879 $13 Million
Q1 2019 May 15, 2019	SELL	$85.97 - $108.09 $2.09 Million - $2.62 Million	-24,266 Reduced 12.69%	166,942 $18 Million
Q4 2018 Feb 14, 2019	SELL	$78.25 - $107.92 $1.2 Million - $1.66 Million	-15,339 Reduced 7.43%	191,208 $16.2 Million
Q3 2018 Nov 14, 2018	SELL	$97.82 - $116.09 $459,753 - $545,623	-4,700 Reduced 2.22%	206,547 $20.3 Million
Q2 2018 Aug 14, 2018	BUY	$97.62 - $120.59 $18.1 Million - $22.3 Million	185,156 Added 709.65%	211,247 $24.4 Million
Q1 2018 May 14, 2018	SELL	$95.91 - $107.26 $7.66 Million - $8.56 Million	-79,850 Reduced 75.37%	26,091 $2.58 Million
Q4 2017 Feb 09, 2018	BUY	$104.5 - $126.38 $11.1 Million - $13.4 Million	105,941	105,941 $11.1 Million

Others Institutions Holding TARO

# of Institutions

Shares Held

17K

Call Options Held

Put Options Held

View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

More about TARO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account